Gilead Sciences to buy Cell Design Labs for $567 million


On Dec. 7, 2017, Gilead Sciences and its cell-therapy subsidiary Kite Pharma announced an agreement to acquire Cell Design Labs, a pre-clinical stage biotherapeutics company specializing in custom cell engineering.

In August, Novartis AG's Kymriah became the first CAR-T cell therapy to get US approval, signaling a new era in the treatment of cancer.

The Cell Design acquisition could expand Gilead's cell therapy capabilities beyond cancer. He is also Cell Design Labs' scientific founder as well as an investigator with the Howard Hughes Medical Institute. The company's lead preclinical compound targets multiple myeloma.

"Cell Design Labs' talented team of cell biology experts will augment and accelerate our work to bring forward new generations of CAR-T and T-cell receptor (TCR) therapies, building on our acquisition of Kite earlier this year and our efforts to improve care for people with advanced cancers", Gilead president and CEO John F. Milligan, Ph.D., said in a statement. Under the terms of the deal, Gilead will initially pay about $175 million and dole out the remaining $322 million to CDL shareholders, other than Kite, following the achievement of certain.

Emeryville, CA-based Cell Design Labs is based on the research of University of California, San Francisco, scientist Wendell Lim.

Throttle, on the other hand, is an on switch that modulates vehicle T activity using small molecules.

Cell Design is a logical next step.

Cell Design Labs is developing several preclinical product candidates, including therapies for prostate cancer and hepatocellular carcinoma that use the synNotch technology. The company says that these technologies are able to engineer cells that are better able to recognize cancer, and in turn, spare healthy tissue.

"This acquisition demonstrates our deep commitment to continuing to invest in future innovation in the field of cellular therapy, both internally and externally", said Gilead CEO John Milligan in a December 7 statement. That's significant because the Kite CAR-T, which was approved to treat cases of non-Hodgkin lymphoma in patients who had failed two other treatments, comes with the risk of an immune response called cytokine release syndrome, in which inflammatory proteins called cytokines are activated in the body.



Related Posts

The "RuPaul's Drag Race" Queens Invade "America's Next Top Model" Cycle 24
It's also been announced that former judge Nigel Barker and season 3 victor of ANTM , Eva Marcille , will make guest appearances. With Drag Race on VH1 now it makes sense to have the queens shanté onto the network's other franchises.

Spot trends and buy/sell signals: Weyerhaeuser Company (WY), Danaher Corporation (DHR)
The company was maintained on Tuesday, April 19 by Citigroup. (NYSE:GNRT) on Thursday, October 19 with "Buy" rating. Riverpoint Mgmt Ltd Liability accumulated 6,064 shares or 0.04% of the stock. (NYSE:URI) for 108,739 shares.

BB&T Corporation (BBT) Shares Sold by Stifel Financial Corp
By 23.24% BB&T Corporation EPS 23.24% will be on a par with past year, analyst expect per share earnings to be lower by 23.24%. The firm owned 93,686 shares of the insurance provider's stock after acquiring an additional 16,421 shares during the quarter.

Dave & Buster's Entertainment's (PLAY) Buy Rating Reaffirmed at Canaccord Genuity
Staying on top of longer-term price action may help provide investors with a wider range of reference when doing stock analysis. Among 10 analysts covering Dave & Buster's Entertainment (NASDAQ: PLAY ), 9 have Buy rating, 0 Sell and 1 Hold.

Google Home job posting suggests touchscreen device is in works
And if this job hunt proves successful, perhaps they'll be able to avoid another debacle like the one that affected the Home Mini.

Al Franken Victim Leeann Tweeden Responds to Democrat's Resignation
She also said she's been the target of "vile and partisan personal attacks" since she disclosed the incidents with Franken . Tim Pawlenty could run for the same seat he planned to seek 15 years ago.

Are Analysts Bearish Enbridge Energy Partners, LP (NYSE:EEP) After Last Week?
Silvercrest Asset Management Limited Co holds 0.11% of its portfolio in Spectra Energy Partners, LP (NYSE:SEP) for 236,586 shares. Mizuho restated a "hold" rating and set a $17.00 target price on shares of Enbridge Energy in a report on Friday, October 20th.

Pa. Lawmaker Defends His Heterosexuality After Being Tapped on Arm
Metcalfe has been outspoken in his belief that homosexuality is a sin and marriage should only be between a man and a woman. Brian Sims, D-Philadelphia, who sits on the committee, is the first openly gay legislator in Pennsylvania .

Quantbot Technologies LP Buys New Holdings in MGIC Investment Corporation (MTG)
Moreover, Westfield Management Ltd Partnership has 0.4% invested in MGIC Investment Corporation (NYSE: MTG ) for 4.24M shares. Jane Street Gru Ltd Limited Liability Company owns 0% invested in MGIC Investment Corporation (NYSE: MTG ) for 31,969 shares.

Senior UN official leaves North Korea after rare visit
Feltman met North Korean Foreign Minister Ri Yong Ho on Thursday and also had two sessions of talks with Vice Foreign Minister Pak Myong Guk.

© 2015 ExpressNewsline. All Rights reserved.